There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on BioMarin Pharmaceutical (BMRN), Twist Bioscience (TWST) and Biogen (BIIB) with bullish sentiments.Meet Samuel – Your Personal Investing ProphetStart a conversation with TipRanks’ trusted, data-backed investment intelligence
Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
BioMarin Pharmaceutical (BMRN)
In a report issued on May 22, Christopher Raymond from Raymond James maintained a Buy rating on BioMarin Pharmaceutical. The company’s shares closed last Friday at $54.09.
According to TipRanks.com, Raymond is a 3-star analyst with an average return of 1.4% and a 43.7% success rate. Raymond covers the Healthcare sector, focusing on stocks such as Biohaven Ltd., Alumis Inc., and Climb Bio.
